IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $31,604,036,000 | +138.2% | 371,681 | -0.7% | 0.02% | +112.5% |
| Q2 2020 | $13,266,503,000 | +73.6% | 374,337 | -34.0% | 0.01% | +60.0% |
| Q1 2020 | $7,642,310,000 | -44.2% | 566,937 | -12.5% | 0.01% | -37.5% |
| Q4 2019 | $13,706,771,000 | -21.0% | 647,768 | -50.5% | 0.01% | -33.3% |
| Q3 2019 | $17,348,125,000 | -2.8% | 1,308,305 | +1.6% | 0.01% | -7.7% |
| Q2 2019 | $17,854,187,000 | -15.4% | 1,287,252 | +17.2% | 0.01% | -18.8% |
| Q1 2019 | $21,092,793,000 | +103.3% | 1,098,011 | +51.0% | 0.02% | +77.8% |
| Q4 2018 | $10,373,691,000 | -24.7% | 726,958 | +9.9% | 0.01% | -10.0% |
| Q3 2018 | $13,773,650,000 | -15.0% | 661,241 | -3.4% | 0.01% | -16.7% |
| Q2 2018 | $16,210,566,000 | +1319.7% | 684,857 | +776.3% | 0.01% | +1100.0% |
| Q1 2018 | $1,141,858,000 | +8.5% | 78,156 | +20.0% | 0.00% | 0.0% |
| Q4 2017 | $1,052,808,000 | +109.7% | 65,149 | +81.4% | 0.00% | – |
| Q3 2017 | $502,035,000 | +61.4% | 35,911 | +1.9% | 0.00% | – |
| Q2 2017 | $311,107,000 | -28.6% | 35,233 | -47.6% | 0.00% | – |
| Q1 2017 | $435,437,000 | +806264.8% | 67,301 | +361.2% | 0.00% | – |
| Q4 2016 | $54,000 | -53.4% | 14,592 | -59.1% | 0.00% | – |
| Q3 2016 | $116,000 | +39.8% | 35,692 | 0.0% | 0.00% | – |
| Q2 2016 | $83,000 | -27.8% | 35,692 | -22.2% | 0.00% | – |
| Q1 2016 | $115,000 | -18.4% | 45,892 | 0.0% | 0.00% | – |
| Q4 2015 | $141,000 | +78.5% | 45,892 | 0.0% | 0.00% | – |
| Q3 2015 | $79,000 | -45.5% | 45,892 | +28.6% | 0.00% | – |
| Q2 2015 | $145,000 | +13.3% | 35,692 | +6.9% | 0.00% | – |
| Q1 2015 | $128,000 | -14.1% | 33,392 | +7.7% | 0.00% | – |
| Q4 2014 | $149,000 | +29.6% | 30,992 | 0.0% | 0.00% | – |
| Q3 2014 | $115,000 | +1.8% | 30,992 | 0.0% | 0.00% | – |
| Q2 2014 | $113,000 | -13.1% | 30,992 | 0.0% | 0.00% | – |
| Q1 2014 | $130,000 | +13.0% | 30,992 | +23.5% | 0.00% | – |
| Q4 2013 | $115,000 | -25.8% | 25,092 | 0.0% | 0.00% | – |
| Q3 2013 | $155,000 | +13.1% | 25,092 | 0.0% | 0.00% | – |
| Q2 2013 | $137,000 | – | 25,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
| First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
| Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
| DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
| Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
| Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
| Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
| Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
| Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |